A network of ultrawealthy investors including Peter Thiel and Sam Altman are infusing the longevity industry with cash and making big bets on where the science is headedBy itskvo / September 8, 2025 This content is locked. Click below to unlock the article (you will be redirected briefly).Unlock Article
